Skip to main content Skip to navigation
Hamburger Menu
Search icon
Location Selector Location Selector
Italy (English)
Profile Icon Profile Icon
Sign-in/Register UserName
Products

Link Arrow
Solutions

Link Arrow
Discover & Learn

Link Arrow
Resources & Tools

Link Arrow
Support

Link Arrow
Close Menu
Website Feedback
Alert Icon
RB705 Mouse Anti-Human CLEC-2A (PILAR)
Product Details
Down Arrow Up Arrow


BD OptiBuild™
CLEC2A; KACL; PILAR; INPE5792; UNQ5792
Human (Tested in Development)
Mouse IgG1, κ
Human CLEC-2A Recombinant Protein
Flow cytometry (Qualified)
0.2 mg/ml
387836
Aqueous buffered solution containing ≤0.09% sodium azide.
RUO


Preparation And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody.
Show More blue down arrow Show Less blue up arrow

Recommended Assay Procedures

BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.

Show More blue down arrow Show Less blue up arrow
757431 Rev. 1
Antibody Details
Down Arrow Up Arrow
705518

The 705518 monoclonal antibody specifically recognizes C-type lectin domain family 2 member A (CLEC-2A) which is also known as Proliferation-induced lymphocyte-associated receptor (PILAR) or Keratinocyte-associated C-type lectin (KACL). CLEC-2A is a ~35 kDa type II transmembrane glycoprotein that is encoded by CLEC2A which belongs to the C-type lectin superfamily. The extracellular region of CLEC-2A contains one C-type lectin domain. CLEC-2A (PILAR) is expressed on keratinocytes and can activate NK cells through binding to their surface KLRF2 molecules. It is also expressed on activated CD8+ T cells and can costimulate proliferative responses upon interaction with CD161.

757431 Rev. 1
Format Details
Down Arrow Up Arrow
RB705
The BD Horizon RealBlue™ 705 (RB705) Dye is part of the BD® family of blue dyes. It is a tandem fluorochrome with an excitation maximum (Ex Max) at 498-nm and an emission maximum (Em Max) at 707-nm as measured using an antibody-dye conjugate. Driven by BD® innovation, RB705 can be used on both spectral and conventional cytometers and is designed to be excited by the Blue laser (488-nm) with minimal excitation by the 561-nm Yellow-Green laser. For conventional instruments equipped with a Blue laser (488-nm), RB705 can be used as an alternative to PerCP-Cy5.5 or BB700 and we recommend using an optical filter centered near 710-nm (e.g., a 695/40 or 710/50-nm bandpass filter). For spectral instruments equipped with a Blue laser (488-nm), it can be used in conjunction with PerCP-Cy5.5. RB705 is on average brighter than PerCP-Cy5.5 and BB700, and has minimal spillover into Yellow-Green detectors.
altImg
RB705
498 nm
707 nm
757431 Rev.1
Citations & References
Down Arrow Up Arrow
View product citations for antibody "757431" on CiteAb
No Citations Found

No Citations Are Available for this Product

757431 Rev. 1

Please refer to Support Documents for Quality Certificates

 

Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described

 

Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.